Industry chiefs say a looming breakthrough might deliver superintelligence. Safety experts say we’re not ready for it. Read ...

Anthropic warned AI could escape human control days after filing for a $965 billion IPO. The Silicon Review asks: safety ...

Recursion Pharmaceuticals reported Q1 2026 progress on its AI-driven drug discovery programs, highlighting its first clinical proof of concept and multiple upcoming trial readouts. The company has ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Casar said the U.S. government can't sit by idly and do nothing. It needs to do something to address the enormous impact of ...

Anthropic warns self-improving AI could emerge sooner than expected and proposes coordinated pause plan among major AI labs ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

A Generalized Recursive Regular Expression Synthesis Framework" by Professor Sangki Ko's research team from the Depa ...

For high school students interested in science, engineering or research, national competitions can be excellent opportunities ...

It’s as if everyone is holding their breath and waiting for what they have been told is coming but, as Pope Leo says, we all ...

Transformer Weekly: The Obernolte-Trahan AI Act, Trump’s executive order, and Anthropic discusses a pause ...